Similarly, AML with NPM1 mutations depends on the menin–KMT2A interaction, and thus the efficacy of menin inhibitors is studied in AML with NPM1 mutation and KMT2A rearrangement [38]. Here, NPM1 is linked to acute myeloid leukemia.